Cochlear (ASX:COH) reiterated its guidance of between 6% and 11% growth in underlying net profit for fiscal 2025, according to a Friday filing with the Australian bourse.
In August, Cochlear reported sales revenue growth of 12% in constant currency and underlying net profit growth of 27% for full fiscal 2024.
The hearing implant manufacturer's shares were up nearly 2% in recent Friday trade.
Price (AUD): $286.02, Change: $+5.20, Percent Change: +1.85%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments